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CASE-LETTER
Erythema Elevatum Diutinum: An
Atypical Presentation
E rythema elevatum diutinum (EED) is classiﬁed within thesmall vessel vasculitis. It is a rare, chronic and progressive
disease affecting mostly extensor surfaces and skin overlying
the joints.1 Clinically, it presents as multiple erythematous and
violaceous papules with a symmetrical and bilateral distribu-
tion. Associations with underlying diseases are common,
including autoimmune disease, malignancies and infections;
although drug-induced cases have been reported. Treatment
varies greatly among the literature, with dapsone being the most
effective and most frequently used drug.2 EED is an important
differential diagnosis of rheumatic disease, especially when
treating patients with chronic arthralgias and nonspeciﬁc cuta-
neous lesions, in whom associated diseases must be ruled out.3
FIGURE 1. (A) Atypical brown rope-like plaques and papules and postinflammatory macules on the patient’s palms. (B) Erythematous
and brownish papules over the helix and antihelix of the patient’s left ear. (C) Typical erythematous papules over the distal interpha-
langeal joint of the patient’s right middle finger. (D) Skin biopsy from a palmar lesion (403 stained with hematoxylin and eosin).
Leukocytoclastic vasculitis with neutrophils, leukocytoclastic debris, lymphocytes and scant eosinophils surrounding the blood vessels.
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We describe a 45-year-old man with chronic joint pain and
atypical hyperpigmented macules in palms, as well as euchro-
matic papules over the ears.
The patient presented with a 2-year history of multiple
papular lesions on the palms and dorsal aspect of hands, knees,
elbows and ears. Some lesions progressed in number and size
over the years, whereas others resolved spontaneously leaving
residual hyperpigmentation. One year later, he developed
arthralgias on elbows, knees, ankles and proximal interphalan-
geal joints. He was treated with nonsteroidal anti-inﬂammatory
drugs without improvement.
On physical examination, he presented with ﬁrm ery-
thematous, red-brown and violaceous papules and nodules of
0.5 to 2.0 cm in diameter, symmetrically distributed over the
extensor surfaces of elbows, knees and proximal interphalan-
geal joints, as well as over the helixes. Linear rope-like papules
and hyperpigmented macules were also noted on his palms
(Fig. 1A–C). The patient referred arthralgias of affected and
nonaffected joints, but no signs of arthritis were documented.
An excisional biopsy from a lesion of his right palm was
performed. Histopathology revealed the presence of leukocyto-
clastic vasculitis with neutrophils, leukocytoclastic debris, lym-
phocytes and scant eosinophils surrounding the blood vessels.
The dermis showed a proliferation of spindle cells combined
with a granulation response (Fig. 1D). Laboratory ﬁndings were
negative or within normal limits.
EED is a rare form of chronic cutaneous vasculitis. The
ﬁrst descriptions of the disease were made by Hutchinson in 1878,
and the disease was later named by Radcliff-Crocker and
Williams in 1892.2 It usually presents with persistent bilateral
brown to erythematous or violaceous papules, nodules and pla-
ques typically located over the extensor surfaces of the extremi-
ties,3 particularly over joints of the hands, elbows and knees and
occasionally on the face and ears. Lesions are mostly asymptom-
atic, although some patients can experience pruritus, tenderness
and a burning sensation after the onset of new lesions. At the time
when lesions appear, they are soft because of dermal edema and
tissue destruction, but as they progress over time, they become
ﬁbrotic and hard on palpation. Differential diagnoses include
granuloma annulare, sarcoidosis, Sweet’s syndrome, pseudolym-
phoma, xanthomas and dermatoﬁbroma.4 EED has a slight male
predominance and is seen in patients between the fourth and sixth
decades. The cause of EED is still unknown, and it is believed to
be a small vessel vasculitis mediated by immune complexes and
has been associated with multiple underlying diseases: autoim-
mune (rheumatoid arthritis, diabetes mellitus, Crohn’s disease and
celiac disease), infections (HIV, streptococcus), malignancies
(B-cell lymphoma, multiple myeloma, breast cancer), and there
are case reports of EED after the use of antituberculosis drugs,
cisplatin and erythropoietin. Histopathological changes vary ac-
cording to the evolution of the lesions and time when the skin
biopsy is taken. Early lesions may mimic features of neutrophilic
dermatoses with polymorphonuclear cells, macrophages and his-
tiocytes, but the presence of leukocytoclastic vasculitis helps to
distinguish EED. In later stages of the disease, a dermal spindle
cell proliferation is observed and lesions can resemble a dermato-
ﬁbroma, and blood vessels show hypertrophic endothelial cells.2
EED shows a chronic, progressive and relapsing course, which
further complicates the treatment, although spontaneous resolu-
tion has been reported after 5 to 10 years. Treatment modalities
include the use of anti-inﬂammatory drugs such as glucocorti-
coids, tetracyclines, nicotinamide, chloroquine, dapsone and
colchicine with variable results. Dapsone is a sulfonamide antibi-
otic that impairs neutrophil function; it is the most effective agent
and remains the mainstay of treatment,5 although recurrences are
common on discontinuation.6 Newer therapies include the use of
topical 5% dapsone preparations7 and plasmapheresis. Because
EED can be associated with a long list of diseases, patients should
be evaluated for related disorders to make prompt and proper
referrals.
The patient presented in this case is of clinical interest
because of the atypical distribution of the lesions, which
usually affect the extensor surfaces. In this case, the main
localization was the palmar region, and instead of papules,
the lesions were more of plaques with a linear rope-like
morphology. Other skin diseases that may present with
palmar rope-like lesions include sarcoidosis, granuloma
annulare, necrobiosis lipoidica, leprosy and multicentric
reticulohistiocytosis. Our patient was initially evaluated for
an underlying autoimmune disease, but clinical and radiolog-
ical as well as laboratory examinations were within the
normal range. Malignancies were also excluded. He was
started on oral dapsone 50 mg/d but eventually denied any
medical treatment and was lost to follow-up.
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